Search

The article provides information on dry eye disease in light of some practical clinical recommendations regarding identification and management of the disease. It offers important considerations for eye care practitioners when caring for patients' ocular surface in the settings of glaucoma. It highlights the multifactorial nature of DED, which involves a combination of tear film instability, ocular surface inflammation, and neurosensory abnormalities.

The article focuses on the pressing global issue of dry eye disease (DED), highlighting its prevalence, impact on quality of life, and economic burden. Topics include the statistics and demographics of DED, its effects on patients' quality of life, and the need for accurate diagnosis and treatment, with a focus on the challenges faced by clinicians in managing this condition.

The article focuses on the application of artificial intelligence (AI) in diagnosing and treating dry eye disease. It highlights three main areas of AI research in this field: analyzing tear film, studying blink patterns, and assessing meibomian glands. It mentions these developments aim to improve the accuracy and efficiency of dry eye diagnosis and provide more objective measurements.

This article discusses the relationship between glaucoma and dry eye disease. Glaucoma patients are more likely to develop dry eye, and the severity and duration of glaucoma treatment can increase the risk. The article emphasizes the importance of managing dry eye in glaucoma patients, as it can impact quality of life and adherence to treatment. It also highlights the various factors that contribute to dry eye, including systemic medications, ocular surgery, and environmental/lifestyle factors. The article suggests individualized treatment options for dry eye, such as prescription medications and in-office procedures, and emphasizes the need for ongoing adjustments to dry eye treatment. [Extracted from the article]

The article reports that Tear Film & Ocular Surface Society's Dry Eye Workshop (DEWS) II Report updated the definition of dry eye disease, describing it as a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film instability with potential damage to the ocular surface. It mentions that increased osmolarity of the tear film and inflammation of the ocular surface focused on meibomian gland dysfunction (MGD).

The article focuses on dry eye disease (DED) is common, proper diagnosis can be a challenge. Signs and symptoms don't always correlate, and patients can present with a wide range of symptoms, if they have any at all. Topics include the clinicians should be prepared to assess patients carefully for DED, which involves a combination of subjective and objective measures, and the proper diagnosis of DED requires an extensive understanding of the condition.

The article offers information on patients have a lot of questions with this diagnosis and how to respond is key to achieving positive outcomes. Topics include the multifactorial nature of the disease makes treating it feel like pulling on the thread of a sweate, and treating dry eye disease (DED) often raises more questions than it answers for both doctors and patients.

The article focuses on concurrent issues such as dry eye, prior surgery or binocular disorders can compromise visual quality. Topics include the optometrists can make the difference and offer patients corrective lenses and other solutions, and the optometric physicians will need to consider the impact of their patient's visual condition when fighting conditions such as dry eye, retinal disease or prior refractive surgery.

The article addresses the effect of diet on ocular health. Topics discussed include impact of dry eye disease (DED) on society, two primary categories of dietary polyunsaturated fatty acids (PUFAs), and three dietary changes brought about by the advent of the agricultural revolution. It also mentions definition of dry eye by the Tear Film and Ocular Surface Society's Dry Eye Workshop II.

The article suggests a new way to assess patients who still struggle with symptoms, and it all begins with a closer look at their eyelid function and dysfunction. It mentions the eyelids are the primary protectors of the tear film, corneal nerves and conjunctiva; and contain the meibomian glands and some of the accessory lacrimal glands critical for tear film stability.

The article focuses on a study that compared the long-term visual outcomes of immediate treatment versus delayed treatment in glaucoma patients and found that delayed treatment did not significantly worsen visual function, indicating that a few years of delayed diagnosis and treatment.

The article offers information on how dry eye to help better diagnose and manage these patients. Topics discussed include information on Tear Film and Ocular Surface Society's Dry Eye Workshop II defined DED; information on dry eye caused by systemic medications such as antihistamines; and diagnosis of DED by eyelid and tear film evaluation.

The article offers information on the diagnosis and treatment of red eye. Topics discussed include rosacea-related rhinophyma, ciliary injection resulting from dilation of anterior ciliary artery branches, performing the visual exam with an acuity assessment, pupil and extraocular motilityevaluation, viral conjunctivitis, chronic keratoconjunctivitis, and pharyngoconjunctival fever, and an increase in allergic conjunctivitis.

The article offers information about clinical finding, dry eye disease (DED) in optometric practice. Topics discussed include decreased tear osmolarity, Schirmer's score and increased meibomian gland dysfunction are symptoms of the disease in women; talks about tear instability of decreased mucin layer caused by goblet cell density reduction; and mentions meibomian gland dysfunction is main cause of DED in type 2 diabetics.

The article evaluates an osmometer offered by Tearlab Osmolarity System company.

The article discusses the treatment for dry-eye disease including Food and Drug Administration (FDA) approved medical device, gel formulation and protein-fragment-based drop. Topics discussed inhibition of inflammatory T-cell mediators, TrueTear Intranasal Tear Neurostimulator device by pharmaceutical company Allergan, and usage of neurostimulation.

The article provides comprehensive overview on the use of tear replacement and tear conservation strategies in managing dry eye disease. Topics discussed include the diagnosis of the diseases' symptoms, the treatment and management of ptaients' dry eye, and the treatment of meibomian gland obstruction. And also notes the common used lipid-based artificial tears which include Refresh Optive Advanced from Allergan, Retaine MGD from OcuSoft, and Systance Balance from Alcon.

The article focuses on the potential protective effect of the Parkinson's drug levodopa against the conversion to wet age-related macular degeneration (AMD). It mentions retrospective analyses and a case-control study suggest that levodopa exposure may reduce the risk of conversion to neovascular AMD, and further research, including a clinical trial, is recommended to explore this potential therapy.

The article focuses on a follow-up study called DREAM, which challenges the efficacy of omega-3 supplementation in the treatment of moderate-to-severe dry eye disease (DED) over a two-year period, suggesting that the initial improvement seen in DED symptoms with omega-3 treatment.

The article focuses on a nationwide study in Denmark that found a higher prevalence of refractive conditions during childhood and adolescence, particularly among offspring of mothers with hypertensive disorder of pregnancy (HDP). It study suggests that altered levels of antiangiogenic factors and increased oxidative stress may contribute to the development of high refractive error in these individuals.

The article discusses treatments for mycotic keratitis, an infection of the cornea caused by yeast or filamentous fungi infiltrating the epithelium, as well as its prevention, rapid detection and diagnosis. It mentions that the effective way of dealing with the fungal infection is through rapid diagnosis and treatment. It adds that the fastest way to diagnose mycotic keratitis is using the polymerase chain reaction test.

The article presents a case study of two eye disease patients who request more information about some educational materials they received. It states that a 56-year-old woman with primary open angle glaucoma (POAG) questioned about her glaucoma treatment. In addition, a 52-year-old woman with ocular hypertension concerned about the performance of her previous doctor.

The article offers information on researchers of a study stress the importance of diagnosing Sjögren's syndrome (SS) early, as the chronic autoimmune condition comes with serious systemic complications, including an increased risk of B-cell non-Hodgkin's lymphoma. Topics include the patients whose primary compliant is dry eye aren't diagnosed, and the team developed is screening questionnaire that can help to identify patients with dry eye with a high likelihood of having underlying SS.

The article offers optometry news briefs including IOP is significantly correlated with body mass index, the distinguish between pellucid marginal degeneration at corneal sublayer pachymetry, and the researchers found that anti-VEGF therapy has provided visual gains for the majority of patients.

The article focuses on the significance of the point-of-care testing (POCT) meant for the diagnosis of eye diseases. It refers to two testing devices useful for eye diseases, falling under POCT called the Adeno Plus from Rapid Pathogen Screening Inc., meant for the keratoconjunctivitis and the TearLab Osmolarity System from TearLab Corp., meant for measuring tears in eyes. It also states that the POCT makes patients repose faith in doctors' diagnostic abilities.